Metastatic Hormone-Sensitive Prostate Cancer Sees Treatment Paradigm Shift

Metastatic Hormone-Sensitive Prostate Cancer Sees Treatment Paradigm Shift

A recent paper in Lancet Oncology concluded that docetaxel added to standard of care should be considered the new standard of care for men with hormone-sensitive metastatic prostate cancer.1,2 One of the studies included in this meta-analysis was …

(Visited 1 times, 1 visits today)
2
Like
Save

Comments

Comments are disabled for this post.